Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers December 3, 2016
Pharmacy Choice - Pharmacy News - December 3, 2016

Pharmacy News

Today's Pharmaceutical and Pharmacy News
Daily News Topic:

FDA News
12/2/16 - Merck & Co., Inc (NYSE:MRK) Gets Coveted Approval For Keytruda
Individual lung cancer patients may soon be able to benefit from Keytruda, an immunotherapy drug from Merck & Co., Inc. (NYSE:MRK). The news comes after the confirmation by the New Jersey drug maker that it had gained a second priority review tag from the US Food and Drug Administration (FDA). Britainâ??s healthcare cost-effectiveness watchdog NIC
12/2/16 - Orthogonal Congratulates Nanowear on the FDA Clearance of their Flagship Product, SimplECG. [Emirates News Agency (WAM) (United Arab Emirates)]
-Orthogonal, a Chicago- based medical device software company, is pleased to congratulate long-term client Nanowear on their recent FDA Class II 510 clearance for their flagship medical device, SimplECG. With this FDA approval, Nanowear has cleared a significant hurdle in commercializing remote cardiac monitoring devices that rely on cloth-based...
12/1/16 - Cardiac Dimensions Announces Investigational Device Exemption Approval from FDA to Conduct U.S. Pivotal Study of the CARILLON Mitral Contour System for Functional Mitral Regurgitation
The multi-center, blinded, randomized controlled trial is designed to evaluate the CARILLON ® Mitral Contour System ® versus guideline directed medical management for the treatment of symptomatic FMR associated with heart failure, a condition affecting an estimated 2 million people in the U.S. 1,2. The CARILLON trial is designed to enroll 400 pat
12/1/16 - FDA approves final trials for MDMA to treat PTSD before legalization review
The US Food and Drug Administration has given the green light to phase three trials of MDMA to treat post-traumatic stress disorder, the final phase of validation required to turn the party drug into a legal medicine. Early trials of the drug, currently listed as a schedule 1 substance by the Drug Enforcement Administration along with heroin and co
12/1/16 - Helsinn Integrative Care Announces 510(K) FDA Clearance for Medical Device Xonrid® Gel
Helsinn Integrative Care, Helsinn's business unit focused on evidence-based, non-pharmaceutical cancer supportive care products, today announces that Xonrid ® Gel, a topical gel for radiotherapy-induced dermatitis, already classified as a medical device in the EU, has received 510 FDA clearance in the US. Riccardo Braglia, Helsinn Group Vice Chair
12/1/16 - Orthogonal Congratulates Nanowear on the FDA Clearance of their Flagship Product, SimplECGâ?¢.
Orthogonal, a Chicago- based medical device software company, is pleased to congratulate long-term client Nanowear on their recent FDA Class II 510 clearance for their flagship medical device, SimplECG. With this FDA approval, Nanowear has cleared a significant hurdle in commercializing remote cardiac monitoring devices that rely on cloth-based...

Chain Drug Review
Chain Drug Review Magazine Chain Drug Review, established in 1978 and published 21 times a year, is recognized as the premier news publication serving the entire chain drug store industry.
Featured Article from Chain Drug Review:
AWP suit settlement appealed
The National Association of Chain Drug Stores has appealed a U.S. District Court’s approval of settlements in the First DataBank Inc. and Medi-Span Inc. lawsuit. »read more

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415